| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Editorial
- Language: English
- [Congenit Anom (Kyoto)] 2024 Jan; Vol. 64 (1), pp. 4-5. <i>Date of Electronic Publication: </i>2024 Jan 01.
- MeSH Terms: Pharmacoepidemiology* ; Research* ; Pregnancy ; Female ; Humans ; Japan / epidemiology
- References: Yakuwa N, Murashima A, Miyazaki S. Investigation on the accumulation of background and pregnancy outcome information on cases consulted by the Japan Drug Information Institute in Pregnancy. Congenital Anorm. 2024;64(1):6-16. doi:10.1111/cga.12547. ; Sakai T, Sato Y, Hatakeyama S, et al. Identification and international comparison of drugs contraindicated for pregnant 34 women in the package inserts. Jpn J Drug Inform. 2023; In press. ; Viguera AC. Accumulation of reproductive safety data for second-generation atypical antipsychotics: a call to accelerate the process. J Clin Psychiatry. 2022;83(4):22com14489. ; Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021;22(3):118-127. ; Takazono T, Tashiro M, Ota Y, et al. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan. Sci Rep. 2020;10(1):15033. ; Kuriyama S, Metoki H, Kikuya M, et al. Cohort profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective. Int J Epidemiol. 2020;49(1):18-19m. ; Davis K, Yost E, Brauneis J, et al. Landscape review of global real-world data sources for studying medication use in pregnancy and lactation that support regulatory decision making. Pharmacoepidemiol Drug Saf. 2023; In press. doi:10.1002/pds.5711. ; Fujioka I, Ohtsu H, Yonemoto N, Sase K, Murashima A. Association between prenatal exposure to antidepressants and neonatal morbidity: an analysis of real-world data from a nationwide claims database in Japan. J Affect Disord. 2022;310:60-67. ; Michihata N, Shigemi D, Yamana H, Matsui H, Jo T, Yasunaga H. Safety of Japanese herbal Kampo medicines for the treatment of depression during pregnancy. Int J Gynaecol Obstet. 2022;159(3):865-869. ; Yamamoto-Sasaki M, Yoshida S, Takeuchi M, Tanaka-Mizuno S, Kawakami K. Association between antidepressant use during pregnancy and congenital anomalies in children: a retrospective cohort study based on Japanese claims data. Congenit Anom. 2020;60(6):180-188. ; Ishikawa T, Nishigori H, Akazawa M, et al. Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: a large claims database study 2010-2019. Pregnancy Hypertens. 2023;31:73-83. ; Kikuchi D, Obara T, Miura R, et al. Trends in the prescription of anti-seizure medicines for pregnant women outpatients with epilepsy during 2016-2020 in Japan. Seizure. 2022;98:101-104. ; Noda A, Obara T, Matsuzaki F, et al. Risk of major congenital malformations associated with the use of Japanese traditional (Kampo) medicine containing ephedra during the first trimester of pregnancy. Drugs Real World Outcomes. 2023, In press. ; Ishikuro M, Obara T, Murakami K, et al. The association between blood pressure control in women during pregnancy and adverse perinatal outcomes: the TMM BirThree cohort study. Hypertens Res. 2023, In press. ; Mito A, Murashima A, Wada Y, et al. Safety of amlodipine in early pregnancy. J Am Heart Assoc. 2019;8(15):e012093. ; Sakai T, Ohtsu F, Mori C, Tanabe K, Goto N. Signal of miscarriage with aripiprazole: a disproportionality analysis of the Japanese adverse drug event report database. Drug Saf. 2017;40(11):1141-1146. ; Nishigori H, Obara T, Nishigori T, et al. Selective serotonin reuptake inhibitors and risk of major congenital anomalies for pregnancies in Japan: a nationwide birth cohort study of the Japan Environment and Children's Study. Congenit Anom. 2017;57(3):72-78. ; Hishinuma K, Yamane R, Yokoo I, et al. Pregnancy outcome after first trimester exposure to domperidone-an observational cohort study. J Obstet Gynaecol Res. 2021;47(5):1704-1710. ; Hatakeyama S, Goto M, Yamamoto A, et al. The safety of pranlukast and montelukast during the first trimester of pregnancy: a prospective, two-centered cohort study in Japan. Congenit Anom. 2022;62(4):161-168. ; Yamaguchi Y, Yamada T, Goto M, et al. Analysis of triptan use during pregnancy in Japan: a case series. Congenit Anom. 2022;62(2):78-81. ; Yakuwa N, Takahashi K, Anzai T, et al. Pregnancy outcomes with exposure to second-generation antipsychotics during the first trimester. J Clin Psychiatry. 2022;83(4):21m14081. ; Nakajima K, Watanabe O, Mochizuki M, Nakasone A, Ishizuka N, Murashima A. Pregnancy outcomes after exposure to tocilizumab: a retrospective analysis of 61 patients in Japan. Mod Rheumatol. 2016;26(5):667-671. ; Richardson JL, Moore A, Bromley RL, et al. Core data elements for pregnancy pharmacovigilance studies using primary source data collection methods: recommendations from the IMI ConcePTION project. Drug Saf. 2023;46(5):479-491. ; Margulis AV, Kawai AT, Anthony MS, Rivero-Ferrer E. Perinatal pharmacoepidemiology: how often are key methodological elements reported in publications? Pharmacoepidemiol Drug Saf. 2022;31(1):61-71. ; Gomes JDA, Olstad EW, Kowalski TW, et al. Genetic susceptibility to drug teratogenicity: a systematic literature review. Front Genet. 2021;12:645555.
- Entry Date(s): Date Created: 20240101 Date Completed: 20240115 Latest Revision: 20240115
- Update Code: 20240115
|
